HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[THE MODERN PROSPECT FOR CITRATE MIXTURES IN THE TREATMENT OF UROLITHIASIS].

Abstract
The authors present a review of literature on the use of litholytic citrate medications for conservative management of urolithiasis. Urate urolithiasis is the most common clinical condition encountered by urologists. Citrate agents, in particular Blemaren, not only may be employed in a conservative therapy of uric acid stones, but can also be successfully used in the treatment of the calcium urolithiasis, i.e. mixed composition stones, which is supported by current international urology guidelines.
AuthorsA K Chepurov, E A Pronkin, A D Bolotov
JournalUrologiia (Moscow, Russia : 1999) (Urologiia) 2015 May-Jun Issue 3 Pg. 93-4, 96 ISSN: 1728-2985 [Print] Russia (Federation)
PMID26390568 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Citrates
  • Urological Agents
  • Uric Acid
Topics
  • Citrates (administration & dosage, therapeutic use)
  • Drug Therapy, Combination
  • Humans
  • Hydrogen-Ion Concentration
  • Uric Acid (blood)
  • Urine (chemistry)
  • Urolithiasis (blood, drug therapy, urine)
  • Urological Agents (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: